- Stephen R. Colen, DDS, MD
- Stephen R. Colen, DDS, MD
- 742 Park Avenue
- New York, NY 10021
- (646) 657-2624
Average Patient Rating
| Takes Time to Listen: | 100 % |
| Communicates Well: | 100 % |
| Average Wait Time: | 8 minutes |
Patient Referrals
"I find everyone at COLEN MD caring,efficent and patient. "
Helpful (0)
Verified on 03-02-2012
"Dr. Colen is a great surgeon. A great surgeon is concerned with long term results of surgery. And as a good doctor he is concerned with his patient's over-all health, as well as improved appearance."
Helpful (0)
Verified on 03-02-2012
"Dr. Colen is excellent. I had a procedure done a couple of years ago and I'm so happy that I have recommended him to many of my friends. "
Helpful (0)
Verified on 02-24-2012
"That the doctor was very straight forward and spent the time needed the explain the options."
Helpful (0)
Unverified, posted on 02-17-2012
"The doctor and the staff were excellent and allayed all my fears. Now I just have to wait. Hope I'll feel as confident when I arrive."
Helpful (0)
Verified on 02-17-2012
"VERY NICE STAFF AND PATIENT DOCTOR. TOOK THE TIME TO EXPLAIN EVERYTHING."
Helpful (0)
Unverified, posted on 02-10-2012
Stephen R. Colen: Related News
(Reuters) - The Internet and women's magazines are filled with enticing adverts for breast implant surgery, but experts and regulators have varying views on how long they last and possible risks.
Debate ensues over uncertified doctors' role in growing field
The rankings are out: The United Health Foundation recently released its annual list of the healthiest U.S. states. Where does your state rank?
Cigarette packs with fewer cigarettes could bolster willpower and help smokers kick their deadly habit, Jody Sindelar says.
The U.S. Food and Drug Administration today launched a new website for patients and caregivers on the safe disposal of needles and other so-called “sharps” that are used at home, at work and while traveling.
Over the past 12 months, the U.S. Food and Drug Administration approved 35 new medicines. This is among the highest number of approvals in the past decade, surpassed only by 2009 (37). Many of the drugs are important advances for patients, including: two new treatments for hepatitis C; a drug for...